GLP-1-Driven Consumer Shift Puts Focus on Functional Food Positioning

According to a recent LinkedIn post from Tastewise, the company’s U.S. consumer panel data suggests that more than eight in ten consumers now define food value by how it makes them feel rather than by quantity. The post connects this shift to rising GLP-1 medication use, citing more than 13 million Americans whose reduced appetites may be driving more selective food purchasing decisions.

The company’s LinkedIn post highlights that products unable to clearly communicate bodily benefits are, according to this view, easier for consumers to forgo. The post further suggests that brands most likely to retain distribution are those with SKUs that quickly convey specific functional benefits, such as protein content, fiber, gut comfort, or blood sugar stability, implying that function is becoming a baseline expectation rather than a differentiator.

For investors, the post points to an evolving demand landscape that could favor food and beverage companies with clearly articulated functional positioning and portfolio focus over broad but undifferentiated assortments. If borne out in market behavior, this trend could reallocate shelf space and marketing spend toward products aligned with GLP-1-driven consumption patterns, potentially benefiting data and insight providers like Tastewise that help brands adapt to these changes.